Sunday 4 October

Connecting Knowledge & People

Featured Topics

Article
Shadow AI And SEC Disclosure: What Your Public Company Needs To Know
When CB Financial Services disclosed a material cybersecurity incident stemming from unauthorized AI use, it revealed a new frontier in corporate governance: shadow AI can trigger SEC disclosure obligations without a traditional cyberattack. This analysis examines how internal AI adoption intersects with materiality determinations, internal controls, and board oversight, offering public companies a framework to identify, assess, and govern AI risks before they become reportable events.
United States Commercial
MG
MGO CPA LLP
Article
The Statute Was The Threat. The Rule Is The Invoice.
Colorado's proposed AI rules transform abstract compliance obligations into concrete operational requirements for financial institutions and businesses deploying automated decision-making systems and customer-facing chatbots. The regulations specify exactly how lenders must explain loan denials, what conversational AI systems must disclose to users, and which documentation companies must maintain to satisfy the Attorney General's enforcement authority under both the Automated Decision-Making Technology Act
United States Technology
Troutman Amin LLP
Article
Mowery & Schoenfeld Promotes Seven New Partners
Mowery & Schoenfeld celebrates its 30th anniversary by promoting seven professionals to partner positions across tax, assurance, transaction advisory, and client advisory services. The promotions include Justin Goetz, Jim Odegard, TJ Van Derpluym, Doug DeLara, Mark Hallgren, Cameron Richey, and Nicole Zambetti, reflecting the firm's commitment to developing leadership from within and positioning for future growth.
United States Accounting
GGI Global Alliance
See more

Webinars

See More

Mondaq's Must Reads

Article
SEC Proposes To Rescind Advisers Act Pay-to-Play Rule (But Don’t Delete Your Policies Yet)
The Securities and Exchange Commission has proposed rescinding the Investment Advisers Act's Pay-to-Play Rule in its entirety, potentially eliminating strict prohibitions on political contributions by investment advisers serving state and local government entities. While this would provide significant relief from the rule's rigid framework and severe penalties for minor violations, advisers must understand that pay-to-play compliance obligations would persist through other federal regulations, state laws....
United States Finance
PR
Proskauer Rose LLP

Trending This Week on Mondaq

Highlighted Content

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology..

Article
The Federal “Stop Corporate Takeovers Of Physicians Act” Introduced, Targeting MSO And Friendly-PC Structures
Federal legislation proposes unprecedented restrictions on corporate ownership of medical practices and management services organizations, potentially disrupting the healthcare industry's reliance on "friendly PC" structures. The Stop Corporate Takeovers of Physicians Act would establish the first federal corporate practice of medicine prohibition, requiring majority physician ownership and control while imposing strict limitations on MSO operations.
United States Healthcare
BB
Bass, Berry & Sims
Article
Pharmaceutical Policy In Motion Continued: The Trump Administration’s Second Wave Of Drug Pricing Deals
The Trump administration's most-favored-nation pricing initiative has expanded to include nine additional mid-sized pharmaceutical manufacturers, bringing the total coverage to 89% of the brand drug market. These new agreements focus on Medicaid pricing discounts aligned with international rates, while manufacturers commit billions to U.S. manufacturing and research in exchange for exemptions from future pricing mandates and potential tariffs.
United States Healthcare
M
Mintz
See more

Related Webinars

See More

Donald Trump Administration

Subscribe

Covers Donald Trump's Presidency, providing expert thought leadership across the various legal practice areas that may be impacted.

Including but not limited to Employment and HR, Immigration, International Law, Environment Law and Technology.

Article
Pharmaceutical Policy In Motion Continued: The Trump Administration’s Second Wave Of Drug Pricing Deals
The Trump administration's most-favored-nation pricing initiative has expanded to include nine additional mid-sized pharmaceutical manufacturers, bringing the total coverage to 89% of the brand drug market. These new agreements focus on Medicaid pricing discounts aligned with international rates, while manufacturers commit billions to U.S. manufacturing and research in exchange for exemptions from future pricing mandates and potential tariffs.
United States Healthcare
M
Mintz
See more

Latest Podcasts

Latest Videos

See more

Upcoming Events

Popular Contributors

Related Country Guides

BR
Banking Regulation
PF
Project Finance
E
ESG
C
Cartels
AB
Anti-Corruption & Bribery
AI
Artificial Intelligence
PM
Private M&A
P
Patents
LF
Litigation Funding
F
Family Law
MC
Merger Control
TD
Trademark Disputes